FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Technical Amendment on Animal Drug Regs

Federal Register notice: FDA posts a technical amendment to its animal drug regulations for labeling new animal drugs included on the agencys Index of...

latest-news-card-1
Medical Devices

FDA OKs Roche HPV Self-Collection Solution

FDA approves the Roche HPV self-collection solution that the company says can expand access and screening options to help eliminate cervical cancer.

latest-news-card-1
Human Drugs

CGMP Violations in Health Specialty Inspection

FDA warns Omaha, NE-based Cohere Beauty about CGMP violations in its Health Specialty drug manufacturing facility in Santa Fe Springs, CA.

latest-news-card-1
Human Drugs

55 Novel Drugs Approved in 2023: Report

The CDER Drug Trials Snapshop Summary Report 2023 provides statistics on the 55 novel drugs the Center approved in 2023.

latest-news-card-1
Biologics

Juno Therapeutics Breyanzi Approved for Lymphoma

FDA grants Juno Therapeutics accelerated approval for its BLA for Breyanzi (lisocabtagene maraleucel), a CAR T cell therapy for adults with relapsed o...

latest-news-card-1
Biologics

Rep Green Bill on Vaccine Data Transparency

Rep. Mark Green (R-TN) introduces the Vaccines in Trial and Liability Act of 2024 that would ensure Americans are protected from fraudulent vaccine tr...

latest-news-card-1
Human Drugs

CGMP Violations in Grupo Contract Test Lab

FDA warns Uruguays Grupo Quimico SRL about CGMP violations in its work as a contract testing laboratory for drug companies.

latest-news-card-1
Federal Register

Day One Bio Granted Pediatric Voucher

Federal Register notice: FDA announces that it issued Day One Biopharmaceuticals a priority review voucher for its recently approved pediatric disease...

latest-news-card-1
Human Drugs

FDA Clears Qiagens Respiratory Panel Plus

FDA clears a Qiagen 510(k) for the QIAstat-Dx Respiratory Panel Plus syndromic test for clinical use in diagnosing upper respiratory infections and co...

latest-news-card-1
Human Drugs

FDA Warns Westwood Labs on CGMP Violations

FDA warns Azusa, CA-based Woodward Laboratories about CGMP violations in its production of finished drugs.